| ■ 영문 제목 : Global Overactive Bladder (OAB) Therapeutics Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02127 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 109 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 과민성 방광 (OAB) 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (항콜린 작용제, 베타3 아드레날린 수용체 작동제)와 용도별 시장규모 (병원, 진료소, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 과민성 방광 (OAB) 치료제 시장 점유율 - 지역별 과민성 방광 (OAB) 치료제 시장규모 - 주요지역의 종류별 시장규모 (항콜린 작용제, 베타3 아드레날린 수용체 작동제) - 주요지역의 용도별 시장규모 (병원, 진료소, 기타) - 미주의 과민성 방광 (OAB) 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 과민성 방광 (OAB) 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 과민성 방광 (OAB) 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 과민성 방광 (OAB) 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 과민성 방광 (OAB) 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Allergan, Astellas Pharma, Hisamitsu Pharmaceutical, Pfizer, Ferring, GlaxoSmithKline, Ion Channel Innovations, Kwang Dong Pharmaceutical, Lanzhou Institute of Biological Products, Merck, ONO Pharmaceutical, Sanofi, Tengion, Teva Pharmaceutical Industries - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Overactive Bladder (OAB) Therapeutics will have significant change from previous year. By the most conservative estimates of global Overactive Bladder (OAB) Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3125 million in 2020. Over the next five years the Overactive Bladder (OAB) Therapeutics market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 3343.7 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder (OAB) Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anticholinergic Agents
Beta-3 Adrenoreceptor Agonists
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hosptial
Clinci
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Allergan
Astellas Pharma
Hisamitsu Pharmaceutical
Pfizer
Ferring
GlaxoSmithKline
Ion Channel Innovations
Kwang Dong Pharmaceutical
Lanzhou Institute of Biological Products
Merck
ONO Pharmaceutical
Sanofi
Tengion
Teva Pharmaceutical Industries
1 Scope of the Report 2 Executive Summary 3 Global Overactive Bladder (OAB) Therapeutics by Company 4 Overactive Bladder (OAB) Therapeutics by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Overactive Bladder (OAB) Therapeutics Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Overactive Bladder (OAB) Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Anticholinergic Agents Table 3. Major Players of Beta-3 Adrenoreceptor Agonists Table 4. Global Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) & (Kg) Table 5. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021) Table 6. Global Overactive Bladder (OAB) Therapeutics Revenue by Type (2016-2021) & ($ million) Table 7. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Type (2016-2021) Table 8. Global Overactive Bladder (OAB) Therapeutics Sale Price by Type (2016-2021) Table 9. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) & (Kg) Table 10. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Table 11. Global Overactive Bladder (OAB) Therapeutics Value by Application (2016-2021) Table 12. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Application (2016-2021) Table 13. Global Overactive Bladder (OAB) Therapeutics Sale Price by Application (2016-2021) Table 14. Global Overactive Bladder (OAB) Therapeutics Sales by Company (2019-2021) & (Kg) Table 15. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Company (2019-2021) Table 16. Global Overactive Bladder (OAB) Therapeutics Revenue by Company (2019-2021) ($ Millions) Table 17. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Company (2019-2021) Table 18. Global Overactive Bladder (OAB) Therapeutics Sale Price by Company (2019-2021) Table 19. Key Manufacturers Overactive Bladder (OAB) Therapeutics Producing Area Distribution and Sales Area Table 20. Players Overactive Bladder (OAB) Therapeutics Products Offered Table 21. Overactive Bladder (OAB) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Overactive Bladder (OAB) Therapeutics Sales by Region (2016-2021) (Kg) Table 25. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2016-2021) Table 26. Global Overactive Bladder (OAB) Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region (2016-2021) Table 28. Americas Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg) Table 29. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021) Table 30. Americas Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021) Table 32. Americas Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) & (Kg) Table 33. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021) Table 34. Americas Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) & (Kg) Table 35. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Table 36. APAC Overactive Bladder (OAB) Therapeutics Sales by Region (2016-2021) & (Kg) Table 37. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2016-2021) Table 38. APAC Overactive Bladder (OAB) Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region (2016-2021) Table 40. APAC Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) & (Kg) Table 41. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021) Table 42. APAC Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) & (Kg) Table 43. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Table 44. Europe Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg) Table 45. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021) Table 46. Europe Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021) Table 48. Europe Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) & (Kg) Table 49. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021) Table 50. Europe Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) & (Kg) Table 51. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg) Table 53. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) & (Kg) Table 57. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) & (Kg) Table 59. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Overactive Bladder (OAB) Therapeutics Table 61. Key Application and Potential Industries of Overactive Bladder (OAB) Therapeutics Table 62. Key Challenges of Overactive Bladder (OAB) Therapeutics Table 63. Key Trends of Overactive Bladder (OAB) Therapeutics Table 64. Overactive Bladder (OAB) Therapeutics Distributors List Table 65. Overactive Bladder (OAB) Therapeutics Customer List Table 66. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2021-2026) & (Kg) Table 67. Global Overactive Bladder (OAB) Therapeutics Consumption Market Forecast by Region Table 68. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2021-2026) & (Kg) Table 71. Americas Overactive Bladder (OAB) Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2021-2026) & (Kg) Table 73. APAC Overactive Bladder (OAB) Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2021-2026) & (Kg) Table 75. Europe Overactive Bladder (OAB) Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2021-2026) & (Kg) Table 77. Middle East & Africa Overactive Bladder (OAB) Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2021-2026) & (Kg) Table 79. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Type (2021-2026) Table 80. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2021-2026) & (Kg) Table 83. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Application (2021-2026) Table 84. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Application (2021-2026) Table 86. Allergan Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 87. Allergan Overactive Bladder (OAB) Therapeutics Product Offered Table 88. Allergan Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 89. Allergan Main Business Table 90. Allergan Latest Developments Table 91. Astellas Pharma Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 92. Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Offered Table 93. Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 94. Astellas Pharma Main Business Table 95. Astellas Pharma Latest Developments Table 96. Hisamitsu Pharmaceutical Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 97. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Offered Table 98. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 99. Hisamitsu Pharmaceutical Main Business Table 100. Hisamitsu Pharmaceutical Latest Developments Table 101. Pfizer Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 102. Pfizer Overactive Bladder (OAB) Therapeutics Product Offered Table 103. Pfizer Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 104. Pfizer Main Business Table 105. Pfizer Latest Developments Table 106. Ferring Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 107. Ferring Overactive Bladder (OAB) Therapeutics Product Offered Table 108. Ferring Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 109. Ferring Main Business Table 110. Ferring Latest Developments Table 111. GlaxoSmithKline Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 112. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Offered Table 113. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 114. GlaxoSmithKline Main Business Table 115. GlaxoSmithKline Latest Developments Table 116. Ion Channel Innovations Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 117. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Offered Table 118. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 119. Ion Channel Innovations Main Business Table 120. Ion Channel Innovations Latest Developments Table 121. Kwang Dong Pharmaceutical Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 122. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Offered Table 123. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 124. Kwang Dong Pharmaceutical Main Business Table 125. Kwang Dong Pharmaceutical Latest Developments Table 126. Lanzhou Institute of Biological Products Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 127. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Offered Table 128. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 129. Lanzhou Institute of Biological Products Main Business Table 130. Lanzhou Institute of Biological Products Latest Developments Table 131. Merck Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 132. Merck Overactive Bladder (OAB) Therapeutics Product Offered Table 133. Merck Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 134. Merck Main Business Table 135. Merck Latest Developments Table 136. ONO Pharmaceutical Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 137. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Offered Table 138. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 139. ONO Pharmaceutical Main Business Table 140. ONO Pharmaceutical Latest Developments Table 141. Sanofi Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 142. Sanofi Overactive Bladder (OAB) Therapeutics Product Offered Table 143. Sanofi Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 144. Sanofi Main Business Table 145. Sanofi Latest Developments Table 146. Tengion Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 147. Tengion Overactive Bladder (OAB) Therapeutics Product Offered Table 148. Tengion Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 149. Tengion Main Business Table 150. Tengion Latest Developments Table 151. Teva Pharmaceutical Industries Basic Information, Overactive Bladder (OAB) Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 152. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Offered Table 153. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 154. Teva Pharmaceutical Industries Main Business Table 155. Teva Pharmaceutical Industries Latest Developments List of Figures Figure 1. Picture of Overactive Bladder (OAB) Therapeutics Figure 2. Overactive Bladder (OAB) Therapeutics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate 2016-2026 (Kg) Figure 7. Global Overactive Bladder (OAB) Therapeutics Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Overactive Bladder (OAB) Therapeutics Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Anticholinergic Agents Figure 10. Product Picture of Beta-3 Adrenoreceptor Agonists Figure 11. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 Figure 12. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Type (2016-2021) Figure 13. Overactive Bladder (OAB) Therapeutics Consumed in Hosptial Figure 14. Global Overactive Bladder (OAB) Therapeutics Market: Hosptial (2016-2021) & (Kg) Figure 15. Overactive Bladder (OAB) Therapeutics Consumed in Clinci Figure 16. Global Overactive Bladder (OAB) Therapeutics Market: Clinci (2016-2021) & (Kg) Figure 17. Overactive Bladder (OAB) Therapeutics Consumed in Other Figure 18. Global Overactive Bladder (OAB) Therapeutics Market: Other (2016-2021) & (Kg) Figure 19. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021) Figure 20. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Application in 2020 Figure 21. Overactive Bladder (OAB) Therapeutics Revenue Market by Company in 2020 ($ Million) Figure 22. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Company in 2020 Figure 23. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Regions (2016-2021) Figure 24. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region in 2020 Figure 25. Americas Overactive Bladder (OAB) Therapeutics Sales 2016-2021 (Kg) Figure 26. Americas Overactive Bladder (OAB) Therapeutics Revenue 2016-2021 ($ Millions) Figure 27. APAC Overactive Bladder (OAB) Therapeutics Sales 2016-2021 (Kg) Figure 28. APAC Overactive Bladder (OAB) Therapeutics Revenue 2016-2021 ($ Millions) Figure 29. Europe Overactive Bladder (OAB) Therapeutics Sales 2016-2021 (Kg) Figure 30. Europe Overactive Bladder (OAB) Therapeutics Revenue 2016-2021 ($ Millions) Figure 31. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales 2016-2021 (Kg) Figure 32. Middle East & Africa Overactive Bladder (OAB) Therapeutics Revenue 2016-2021 ($ Millions) Figure 33. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2020 Figure 34. Americas Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country in 2020 Figure 35. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 Figure 36. Americas Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2020 Figure 37. United States Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 38. Canada Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 39. Mexico Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 40. Brazil Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 41. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2020 Figure 42. APAC Overactive Bladder (OAB) Therapeutics Revenue Market Share by Regions in 2020 Figure 43. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 Figure 44. APAC Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2020 Figure 45. China Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 46. Japan Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 47. Korea Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 48. Southeast Asia Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 49. India Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 50. Australia Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 51. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2020 Figure 52. Europe Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country in 2020 Figure 53. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 Figure 54. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2020 Figure 55. Germany Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 56. France Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 57. UK Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 58. Italy Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 59. Russia Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 60. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2020 Figure 61. Middle East & Africa Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country in 2020 Figure 62. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 Figure 63. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2020 Figure 64. Egypt Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 65. South Africa Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 66. Israel Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 67. Turkey Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 68. GCC Country Overactive Bladder (OAB) Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 69. Channels of Distribution Figure 70. Distributors Profiles |
| ※본 조사보고서 [세계의 과민성 방광 (OAB) 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02127) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 과민성 방광 (OAB) 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |